Evidence map›Paper›PMID 29581149›Full record

ArticleMolecular systems biology2018

High-resolution definition of humoral immune response correlates of effective immunity against HIV.

Galit Alter, Karen G Dowell, Eric P Brown, Todd J Suscovich, Anastassia Mikhailova, Alison E Mahan, Bruce D Walker, Falk Nimmerjahn, Chris Bailey-Kellogg, Margaret E Ackerman

Open access · goldAbstract read
In one paragraph

Article in Molecular systems biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 48 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Galit AlterRagon Institute of MGH, MIT and Harvard, Cambridge, MA, USA.
Karen G DowellDepartment of Computer Science, Dartmouth College, Hanover, NH, USA.
Eric P BrownThayer School of Engineering, Dartmouth College, Hanover, NH, USA.
Todd J SuscovichRagon Institute of MGH, MIT and Harvard, Cambridge, MA, USA.
Anastassia MikhailovaRagon Institute of MGH, MIT and Harvard, Cambridge, MA, USA.
Alison E MahanRagon Institute of MGH, MIT and Harvard, Cambridge, MA, USA.
Bruce D WalkerRagon Institute of MGH, MIT and Harvard, Cambridge, MA, USA.
Falk NimmerjahnDepartment of Biology, Institute of Genetics, University of Erlangen-Nuremberg, Erlangen, Germany.
Chris Bailey-KelloggDepartment of Computer Science, Dartmouth College, Hanover, NH, USA.
Margaret E AckermanThayer School of Engineering, Dartmouth College, Hanover, NH, USA margaret.e.ackerman@dartmouth.edu.ORCID 0000-0002-4253-3476
Ragon Institute of MGH, MIT and Harvard · USDartmouth College · USFriedrich-Alexander-Universität Erlangen-Nürnberg · DE

Funding

Physical Resources CoreP01AI120756 · NIAID · DUKE UNIVERSITY · PI TOMARAS, GEORGIA DORIS · 2016 to 2020
$17.1M
Directing Antibody Effector Activity via Controlled IgG Subclass SwitchingR01AI131975 · NIAID · DARTMOUTH COLLEGE · PI ACKERMAN, MARGARET E · 2017 to 2020
$2.6M
Applying High-Performance Protein Engineering Tools to HIV Immunogen DesignR01AI102691 · NIAID · DARTMOUTH COLLEGE · PI ACKERMAN, MARGARET E · 2012 to 2015
$2.2M
NIAID NIH HHS P01 AI120756NIAID NIH HHS R01 AI102691NIAID NIH HHS R01 AI131975
6 · The paper itself

Abstract

Defining correlates of immunity by comprehensively interrogating the extensive biological diversity in naturally or experimentally protected subjects may provide insights critical for guiding the development of effective vaccines and antibody-based therapies. We report advances in a humoral immunoprofiling approach and its application to elucidate hallmarks of effective HIV-1 viral control. Systematic serological analysis for a cohort of HIV-infected subjects with varying viral control was conducted using both a high-resolution, high-throughput biophysical antibody profiling approach, providing unbiased dissection of the humoral response, along with functional antibody assays, characterizing antibody-directed effector functions such as complement fixation and phagocytosis that are central to protective immunity. Profiles of subjects with varying viral control were computationally analyzed and modeled in order to deconvolute relationships among IgG Fab properties, Fc characteristics, and effector functions and to identify humoral correlates of potent antiviral antibody-directed effector activity and effective viral suppression. The resulting models reveal multifaceted and coordinated contributions of polyclonal antibodies to diverse antiviral responses, and suggest key biophysical features predictive of viral control.

Indexed as

Antibodies, ViralComplement Fixation TestsComputational BiologyHIV-1HIV InfectionsHumansImmunity, HumoralPhagocytosisAntibodies, Viralantibodyeffector functionHIVsystems serology

Identifiers

PMID29581149
PMCPMC5868198
OpenAlexW2791890022

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.